Home Pilots Neurotechnology company Cognito Therapeutics scores $73M Pilots Neurotechnology company Cognito Therapeutics scores $73M By - March 23, 2023 33 0 Facebook Twitter Pinterest WhatsApp The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer’s disease. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES MediView XR receives 510(k) clearance for AR surgical navigation platform Pilots - July 17, 2023 0 Curebase, Meru Health partner to study digital depression treatment Pilots - September 21, 2022 0 Israeli startup CytoReason raises $80M to expand AI model, open hub in Massachusetts Pilots - July 19, 2024 0 ‘Much bigger than just a global pandemic’: How hospitals can plan crisis EHR documentation Pilots - February 11, 2022 0 Mark Cuban Cost Plus Drug Company partners with elderly care coordination app Pilots - October 5, 2023 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3